Rankings
▼
Calendar
BEAM FY 2017 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$9M
Net Income
-$9M
EPS (Diluted)
$-0.62
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$198,000
Balance Sheet
Total Assets
$2M
Total Liabilities
$7M
Stockholders' Equity
-$4M
Cash & Equivalents
$2M
← Q1 2018
All Quarters